Skip to main content

Mutagenicity and carcinogenicity of biological reactive intermediate's derived from a "non-genotoxic" carcinogen.

Publication ,  Journal Article
Lau, SS; Yoon, HS; Patel, SK; Everitt, JI; Walker, CL; Monks, TJ
Published in: Adv Exp Med Biol
2001

Duke Scholars

Published In

Adv Exp Med Biol

ISSN

0065-2598

Publication Date

2001

Volume

500

Start / End Page

83 / 92

Location

United States

Related Subject Headings

  • Tumor Suppressor Proteins
  • Tuberous Sclerosis Complex 2 Protein
  • Repressor Proteins
  • Mutagens
  • Loss of Heterozygosity
  • Kidney Neoplasms
  • Kidney
  • Hydroquinones
  • Humans
  • Glutathione
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lau, S. S., Yoon, H. S., Patel, S. K., Everitt, J. I., Walker, C. L., & Monks, T. J. (2001). Mutagenicity and carcinogenicity of biological reactive intermediate's derived from a "non-genotoxic" carcinogen. Adv Exp Med Biol, 500, 83–92.
Lau, S. S., H. S. Yoon, S. K. Patel, J. I. Everitt, C. L. Walker, and T. J. Monks. “Mutagenicity and carcinogenicity of biological reactive intermediate's derived from a "non-genotoxic" carcinogen.Adv Exp Med Biol 500 (2001): 83–92.
Lau SS, Yoon HS, Patel SK, Everitt JI, Walker CL, Monks TJ. Mutagenicity and carcinogenicity of biological reactive intermediate's derived from a "non-genotoxic" carcinogen. Adv Exp Med Biol. 2001;500:83–92.
Lau SS, Yoon HS, Patel SK, Everitt JI, Walker CL, Monks TJ. Mutagenicity and carcinogenicity of biological reactive intermediate's derived from a "non-genotoxic" carcinogen. Adv Exp Med Biol. 2001;500:83–92.

Published In

Adv Exp Med Biol

ISSN

0065-2598

Publication Date

2001

Volume

500

Start / End Page

83 / 92

Location

United States

Related Subject Headings

  • Tumor Suppressor Proteins
  • Tuberous Sclerosis Complex 2 Protein
  • Repressor Proteins
  • Mutagens
  • Loss of Heterozygosity
  • Kidney Neoplasms
  • Kidney
  • Hydroquinones
  • Humans
  • Glutathione